The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Placebo Outperforms Glucosamine/Chondroitin Sulfate for Knee OA

Placebo Outperforms Glucosamine/Chondroitin Sulfate for Knee OA

August 24, 2016 • By Erin Blakemore

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In 2015, Lapane reported similar findings from a four-year follow-up analysis on glucosamine and chondroitin using data from the National Institutes of Health’s Osteoarthritis Initiative.

You Might Also Like
  • Does Chondroitin Trump Celecoxib for Arthritic Knee Pain?
  • Glucosamine Supplements Don’t Help Knee or Hip Arthritis Pain
  • New Research Shows Chondroitin Sulphate Reduces Cartilage Volume Loss, Bone Marrow Lesions

“These supplements can be costly and are not covered by health insurance,” notes Lapane. “Patients should consider the fact that they have not been proven to be efficacious before spending money on glucosamine/chondroitin supplements for osteoarthritis.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The trial, which was funded by Spanish pharmaceutical company Tedec Meiji Farma SA, was the first to evaluate the efficacy of a combination of both drugs and include a data safety monitoring board to ensure bias-free data. Tedec Meiji did not participate in the study’s design or administration.

Pages: 1 2 | Single Page

Filed Under: Conditions, Drug Updates, Osteoarthritis Tagged With: Arthritis & Rheumatology, chondroitin sulfate, glucosamine sulfate, knee, Knee Osteoarthritis (OA), knee pain, placebo

You Might Also Like:
  • Does Chondroitin Trump Celecoxib for Arthritic Knee Pain?
  • Glucosamine Supplements Don’t Help Knee or Hip Arthritis Pain
  • New Research Shows Chondroitin Sulphate Reduces Cartilage Volume Loss, Bone Marrow Lesions
  • Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.